Newsletter | September 19, 2024

09.19.24 -- The Influence Of Flows In cGMP Architectural Design

SPONSOR

Mabion Capacity Update July 2024: Large Molecule Development

Explore our new installations in upstream development, new bioreactors, as well as downstream development and fill-finish. This state of the art EU-GMP certified facility is staffed by a team of 250 professionals, and capacity is now available.

FEATURED EDITORIAL

The Influence Of Flows In cGMP Architectural Design

In drug manufacturing facility layout, balancing the roles of layout and procedure plays a critical role. This article examines how the interplay may be resolved, and how this resolution affects facility layout during design.

Should You Be Using Unique Container Identification?

Unique identifiers on glass vials could solve a host of problems. ISPE developed a new guide to help manufacturers apply them on primary parenteral containers.

INDUSTRY INSIGHTS

Selecting Container Closure Systems With Confidence: Lyophilization

Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.

Cell Line Preparation For Optimal Production

Discover an experienced, flexible, and capable partner that can help you optimize production from MCB and WCB manufacturing to safe cell bank storage.

SPONSOR

BIOCHINA 2025

Join BIOCHINA 2025, the must-attend event for biotech professionals! Unlock opportunities in drug licensing, optimize your supply chain, supercharge your product promotion, and access crucial funding sources. With over 500 Chinese exhibitors, 50+ global exhibitors, 30,000+ attendees, 3,000+ biotech companies, and 1,000+ 1v1 partnering sessions, this is your chance to connect with industry leaders and drive your business forward. Don't miss out!

SOLUTIONS

Mabion Capacity Update July 2024: Large Molecule Development